Michael Weintraub

Michael Weintraub was the founder of Humedica, Inc., founded in 2008, where the titles held included President, Chief Executive Officer & Director from 2011 to 2013.
Mr. Weintraub is the founder of Ardan Equity Partners LLC, founded in 2019, holding the title of Managing Partner since 2019.
Current jobs include Chairman at BroadReach Healthcare LLC since 2018, Chairman at Phreesia, Inc. since 2005, Chairman at Holmusk USA, Inc., Chairman at Holmusk Europe Ltd. since 2005, Board of Director at Apixio LLC since 2023, Director at Atropos Health, Inc. since 2024, Director at Forsyth Health LLC since 2023, Director at Panalgo LLC since 2021, Director at CorEvitas LLC since 2021, Director at Oncology Analytics, Inc. since 2019, Director at Newfire LLC since 2019, Director at The College Diabetes Network, and Director at Ardan Investment Co. II LP.
Former jobs include President & Chief Executive Officer at UnitedHealth Group, Inc. from 2013 to 2017, President & Chief Executive Officer at PharMetrics, Inc. from 2001 to 2005, Chief Executive Officer-Optum Analytics at InGensa, Inc. from 2013 to 2017, Senior Managing Director at Leerink Partners LLC from 2007 to 2008, Director at OncoHealth Corp., Director at Mindstrong, Inc., Chief Operating Officer at eLoyalty Corp.
from 1997 to 2001, SVP at OSO BioPharmaceuticals Manufacturing LLC from 1987 to 1993, VP & GM at Amherst Associates, Inc. from 1981 to 1986, President at Truven Health Analytics, Inc. from 1993 to 1997, and Managing Partner at Optum Venture Management LLC from 2017 to 2018.
Education includes undergraduate studies at Brandeis University and an MBA from Harvard Business School.